Company · CIK 0001631650 · SIC 2834 — Pharmaceutical Preparations
Aimmune Therapeutics, Inc. · AIMT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2017 MForm 4 → | Apr 5, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 15,000 | $3.02 | $45,330 | 35,681 | — | plan? |
| Mar 21, 2017 SForm 4 → | Mar 23, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 10,000 | $22.95 | $229,500 | 20,681 | −32.6% | plan? |
| Mar 21, 2017 MForm 4 → | Mar 23, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 10,000 | $3.02 | $30,220 | 30,681 | — | plan? |
| Feb 3, 2017 FForm 4 → | Feb 3, 6:47 pm EST | Jeffrey H KnappChief Operating Officer | 2,224 | $17.89 | $39,787 | 2,776 | — | plan? |
| Jan 11, 2017 MForm 4 → | Jan 13, 4:05 pm EST | Warren L. DeSouzaChief Financial Officer | 20,681 | $3.02 | $62,498 | 20,681 | — | plan? |
| Nov 29, 2016 JForm 4 → | Dec 6, 8:11 pm EST | Mary M. RozenmanSee Remarks | 129 | — | — | 129 | — | plan? late |
| Nov 29, 2016 JForm 4 → | Dec 1, 9:52 pm EST | Patrick G EnrightDirector, 10% Owner | 1,507,276 | — | — | 7,276 | — | plan? |
| Nov 29, 2016 JForm 4 → | Dec 1, 9:50 pm EST | Longitude Capital Partners II, LLC +210% Owner | 1,507,276 | — | — | 7,276 | — | plan? |
| Nov 11, 2016 SForm 4 → | Nov 15, 4:06 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | $25.00 | $500,000 | 0 | −100% | plan? |
| Nov 11, 2016 MForm 4 → | Nov 15, 4:06 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | $3.02 | $60,440 | 20,000 | — | plan? |
| Nov 10, 2016 SForm 4 → | Nov 15, 4:05 pm EST | Stephen George DillySee Remarks, Director | 50,000 | $25.01 | $1,250,590 | 715,308 | −6.53% | plan? late |
| Nov 8, 2016 SForm 4 → | Nov 10, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | $20.00 | $300,000 | 0 | −100% | plan? |
| Nov 8, 2016 MForm 4 → | Nov 10, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | $3.02 | $45,330 | 15,000 | — | plan? |
| Nov 4, 2016 SForm 4 → | Nov 4, 4:08 pm EDT | Mary M. RozenmanSee Remarks | 24,096 | $17.60 | $424,090 | 0 | −100% | plan? |
| Nov 4, 2016 MForm 4 → | Nov 4, 4:08 pm EDT | Mary M. RozenmanSee Remarks | 24,096 | $3.02 | $72,818 | 24,096 | — | plan? |
| Oct 5, 2016 SForm 4 → | Oct 7, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 25,000 | $16.80 | $420,000 | 0 | −100% | plan? |
| Oct 5, 2016 MForm 4 → | Oct 7, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 25,000 | $3.02 | $75,550 | 25,000 | — | plan? |
| Sep 8, 2016 SForm 4 → | Sep 9, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | $16.80 | $504,000 | 0 | −100% | plan? |
| Sep 8, 2016 MForm 4 → | Sep 9, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | $3.02 | $90,660 | 30,000 | — | plan? |
| Jul 25, 2016 GForm 4 → | Nov 15, 4:05 pm EST | Stephen George DillySee Remarks, Director | 115,576 | — | — | 14,447 | — | plan? late |
| May 31, 2016 SForm 4 → | Jun 2, 5:40 pm EDT | Foresite Capital Management II, LLC +410% Owner | 240,000 | $15.23 | $3,654,720 | 235,020 | −50.5% | plan? |
| Apr 29, 2016 AForm 4 → | Apr 29, 8:15 pm EDT | Douglas T. SheehySee Remarks | 12,000 | — | — | 12,000 | — | plan? |
| Mar 29, 2016 PForm 4 → | Mar 31, 5:01 pm EDT | Patrick G EnrightDirector, 10% Owner | 78,504 | $13.87 | $1,089,135 | 7,513,134 | +1.06% | plan? |
| Mar 29, 2016 PForm 4 → | Mar 31, 4:59 pm EDT | Longitude Capital Partners II, LLC +310% Owner | 78,504 | $13.87 | $1,089,135 | 7,513,134 | +1.06% | plan? |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:43 pm EST | Jeffrey H KnappChief Operating Officer | 5,000 | — | — | 5,000 | — | plan? |
| Aug 24, 2015 PForm 4 → | Aug 26, 4:59 pm EDT | Foresite Capital Management II, LLC +410% Owner | 25,485 | $19.65 | $500,900 | 355,020 | +7.73% | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:49 am EDT | Longitude Capital Partners II, LLC +310% Owner | 312,500 | $16.00 | $5,000,000 | 7,434,630 | +4.39% | plan? |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:49 am EDT | Longitude Capital Partners II, LLC +310% Owner | 7,122,130 | — | — | 7,122,130 | — | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:46 am EDT | Foresite Capital Management II, LLC +410% Owner | 642,035 | $16.12 | $10,349,199 | 329,535 | — | plan? |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:46 am EDT | Foresite Capital Management II, LLC +410% Owner | 3,775,400 | — | — | 3,775,400 | — | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:40 am EDT | Mark T IwickiDirector | 20,000 | $16.00 | $320,000 | 20,000 | — | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:36 am EDT | Mark McDadeDirector | 16,660 | $16.00 | $266,560 | 16,660 | — | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:33 am EDT | Kathryn E FalbergDirector | 25,000 | $16.00 | $400,000 | 94,894 | +35.8% | plan? |
| Aug 11, 2015 PForm 4 → | Aug 11, 11:29 am EDT | Patrick G EnrightDirector, 10% Owner | 312,500 | $16.00 | $5,000,000 | 7,434,630 | +4.39% | plan? |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:29 am EDT | Patrick G EnrightDirector, 10% Owner | 7,122,130 | — | — | 7,122,130 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Douglas T. SheehySee Remarks | 75,000 | — | — | 75,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 71,250 | — | — | 71,250 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Eric BjerkholtChief Financial Officer | 78,750 | — | — | 78,750 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Mary M. RozenmanSee Remarks | 45,000 | — | — | 45,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:05 pm EST | Jayson Donald Alexander DallasPresident and CEO, Director | 210,000 | — | — | 210,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:06 pm EST | Andrew OxtobyChief Commercial Officer | 150,000 | — | — | 150,000 | — | |
| Nov 19, 2018 MForm 4 → | Nov 21, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 40,000 | — | — | 53,400 | — | |
| Jun 19, 2018 AForm 4 → | Jun 19, 7:06 pm EDT | Jayson Donald Alexander DallasPresident and CEO, Director | 350,000 | — | — | 350,000 | — | |
| Jun 11, 2018 MForm 4 → | Jun 13, 4:06 pm EDT | Stephen George DillyPresident and CEO, Director | 29,457 | — | — | 295,942 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:50 pm EDT | Stephen George DillyPresident and CEO, Director | 105,169 | — | — | 325,399 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 7:20 pm EDT | Stephen George DillySee Remarks, Director | 165,374 | — | — | 430,568 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Patrick G EnrightDirector, 10% Owner | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Stacey Denenberg SeltzerDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:08 pm EDT | Gregory BeharDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Mark T IwickiDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Kathryn E FalbergDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:05 pm EDT | Mark McDadeDirector | 7,500 | — | — | 7,500 | — | |
| May 22, 2018 MForm 4 → | May 24, 5:09 pm EDT | Douglas T. SheehySee Remarks | 3,296 | — | — | 63,649 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Jeffrey H KnappChief Operating Officer | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:41 pm EST | Mary M. RozenmanSee Remarks | 41,250 | — | — | 41,250 | — | |
| Mar 4, 2018 AMForm 4 → | Mar 6, 8:40 pm EST | Douglas T. SheehySee Remarks | 78,523 | — | — | 66,945 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:40 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:39 pm EST | Eric BjerkholtChief Financial Officer | 56,250 | — | — | 56,250 | — | |
| Mar 1, 2018 MForm 4 → | Mar 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 1,807 | — | — | 105,436 | — | |
| Feb 5, 2018 MForm 4 → | Feb 7, 4:06 pm EST | Douglas T. SheehySee Remarks | 1,648 | — | — | 68,593 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,592 | — | — | 107,243 | — | |
| Jan 24, 2018 MForm 4 → | Jan 26, 5:32 pm EST | Douglas T. SheehySee Remarks | 1,875 | — | — | 69,375 | — | |
| Jan 12, 2018 MForm 4 → | Jan 16, 6:05 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 36,717 | — | — | 190,000 | — | |
| Jan 4, 2018 MForm 4 → | Jan 8, 4:07 pm EST | Douglas T. SheehySee Remarks | 1,648 | — | — | 70,241 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,591 | — | — | 113,835 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 75,000 | — | — | 93,400 | — | |
| Dec 27, 2017 MForm 4 → | Dec 29, 5:26 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 3,283 | — | — | 226,717 | — | |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:45 pm EST | Mary M. RozenmanSee Remarks | 75,010 | — | — | 120,426 | — | |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:43 pm EST | Douglas T. SheehySee Remarks | 1,875 | — | — | 71,250 | — | |
| Dec 4, 2017 MForm 4 → | Dec 6, 4:05 pm EST | Douglas T. SheehySee Remarks | 1,906 | — | — | 71,889 | — | |
| Nov 30, 2017 MForm 4 → | Dec 4, 4:05 pm EST | Douglas T. SheehySee Remarks | 3,750 | — | — | 73,125 | — | |
| Nov 9, 2017 MForm 4 → | Nov 13, 5:26 pm EST | Douglas T. SheehySee Remarks | 1,905 | — | — | 73,795 | — | |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | — | — | 230,000 | — | |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Douglas T. SheehySee Remarks | 47,425 | — | — | 76,875 | — | |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:06 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | — | — | 240,000 | — | |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | — | — | 168,400 | — | |
| Sep 7, 2017 MForm 4 → | Sep 11, 5:17 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | — | — | 195,436 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 18,390 | — | — | 188,400 | — | |
| Jul 27, 2017 MForm 4 → | Jul 31, 5:50 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 500 | — | — | 206,790 | — | |
| Jul 21, 2017 MForm 4 → | Jul 25, 6:35 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 6,110 | — | — | 207,290 | — | |
| Jul 13, 2017 MForm 4 → | Jul 17, 4:31 pm EDT | Mary M. RozenmanSee Remarks | 14,940 | — | — | 225,436 | — | |
| Jul 3, 2017 MForm 4 → | Jul 6, 5:01 pm EDT | Mary M. RozenmanSee Remarks | 45,060 | — | — | 225,319 | — | |
| Jul 3, 2017 MForm 4 → | Jul 6, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | — | — | 213,400 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:06 pm EDT | Kathryn E FalbergDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:06 pm EDT | Stacey Denenberg SeltzerDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Patrick G EnrightDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Mark T IwickiDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Gregory BeharDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Mark McDadeDirector | 17,500 | — | — | 17,500 | — | |
| Apr 28, 2017 AForm 4 → | May 1, 4:33 pm EDT | Eric BjerkholtChief Financial Officer | 270,000 | — | — | 270,000 | — | |
| Apr 3, 2017 MForm 4 → | Apr 5, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 15,000 | — | — | 303,794 | — | |
| Mar 21, 2017 MForm 4 → | Mar 23, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 10,000 | — | — | 318,794 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:40 pm EST | Jeffrey H KnappChief Operating Officer | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:40 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:39 pm EST | Douglas T. SheehySee Remarks | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:38 pm EST | Stephen George DillySee Remarks, Director | 240,000 | — | — | 240,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:36 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:36 pm EST | Mary M. RozenmanSee Remarks | 60,000 | — | — | 60,000 | — | |
| Jan 11, 2017 MForm 4 → | Jan 13, 4:05 pm EST | Warren L. DeSouzaChief Financial Officer | 20,681 | — | — | 328,794 | — | |
| Nov 23, 2016 AForm 4 → | Nov 28, 4:05 pm EST | Gregory BeharDirector | 39,510 | — | — | 39,510 | — | |
| Nov 11, 2016 MForm 4 → | Nov 15, 4:06 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | — | — | 228,400 | — | |
| Nov 8, 2016 MForm 4 → | Nov 10, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | — | — | 248,400 | — | |
| Nov 4, 2016 MForm 4 → | Nov 4, 4:08 pm EDT | Mary M. RozenmanSee Remarks | 24,096 | — | — | 270,379 | — | |
| Oct 5, 2016 MForm 4 → | Oct 7, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 25,000 | — | — | 294,475 | — | |
| Sep 8, 2016 MForm 4 → | Sep 9, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | — | — | 319,475 | — | |
| Jun 24, 2016 AForm 4 → | Jun 24, 5:20 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 250,000 | — | — | 250,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:06 pm EDT | Mark T IwickiDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:06 pm EDT | Patrick G EnrightDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Mark McDadeDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Kathryn E FalbergDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Stacey Denenberg SeltzerDirector | 19,755 | — | — | 19,755 | — | |
| Apr 29, 2016 AForm 4 → | Apr 29, 8:15 pm EDT | Douglas T. SheehySee Remarks | 110,000 | — | — | 110,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:47 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:43 pm EST | Jeffrey H KnappChief Operating Officer | 250,000 | — | — | 250,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:42 pm EST | Warren L. DeSouzaChief Financial Officer | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:41 pm EST | Stephen George DillySee Remarks, Director | 240,000 | — | — | 240,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:41 pm EST | Mary M. RozenmanSee Remarks | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:35 pm EST | Robert Myles ElfontChief Medical Officer | 80,000 | — | — | 80,000 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:49 am EDT | Longitude Capital Partners II, LLC +310% Owner | 7,122,130 | — | — | 0 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:46 am EDT | Foresite Capital Management II, LLC +410% Owner | 3,775,400 | — | — | 0 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:29 am EDT | Patrick G EnrightDirector, 10% Owner | 7,122,130 | — | — | 0 | — |